What the FDA’s “Table of Pharmacogenetic Associations” says about psychotropic medications

In February 2020, the United States Food and Drug Administration (FDA) announced a “Collaborative Review of Scientific Evidence to Support Associations Between Genetic Information and Specific Medications”. What is helpful for clinicians is that the FDA also published a Table of Pharmacogenetic Associations with information on how pharmacogenetic information affects various medications. This table provides…